This quarter’s issue includes summaries and associated court opinions of selected cases principally decided between February and April 2022. Cryptocurrency Derivative Litigation.
StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the stock. Other equities research analysts have also issued reports about the stock. Zacks Investment Research lowered shares of Chembio Diagnostics from a “hold” rating […]
Chembio Diagnostics, Inc. (NASDAQ:NASDAQ:CEMI) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Rick Eberly - President & Chief Executive Officer Larry.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.